Excess risk of primary liver cancer in patients with diabetes mellitus

Journal of the National Cancer Institute

Volumn 88, Issue 20, 1996, Pages 1472-1477

  Adami, Hans Olov ^c   Chow, Wong Ho ^a,b   Nyrén, Olof ^c   Berne, Christian ^c   Linet, Martha S ^d   Ekbom, Anders ^f   Wolk, Alicja ^c   McLaughlin, Joseph K ^e   Fraumeni Jr , Joseph F ^d  

^a INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d National Cancer Institute   (Sweden)

^e Iternational Epidemiology Institute

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; GALLBLADDER CANCER; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; VATER PAPILLA CARCINOMA;

ADULT; AGED; BILIARY TRACT NEOPLASMS; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; RISK; RISK FACTORS;

EID: 0029821203     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.20.1472     Document Type: Article

References (42)

1. Cancer: causes, occurrence and control. IARC Sci Publ 1990;100:1-352.
2. La Vecchia C, Negri E, Franceschi SD, D'Avanzo B, Boyle P. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994;70:950-3.
3. Kingston ME, Ali MA, Atiyeh M, Donnelly RJ. Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology 1984;87:688-94.
4. Lawson DH, Gray JM, McKillop C, Clarke J, Lee FD, Patrick RS. Diabetes mellitus and primary hepatocellular carcinoma. Q J Med 1986;61: 945-55.
5. La Vecchia C, Negri E, D'Avanzo B, Boyle P, Franceschi S. Medical history and primary liver cancer. Cancer Res 1990;50:6274-7.
6. Yu MC, Tong MJ, Govindarajan S, Henderson BE. Nonrival risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.
7. Lu SN, Lin TM, Chen CJ, Chen JS, Liaw YF, Chang WY, et al. A casecontrol study of primary hepatocellular carcinoma in Taiwan. Cancer 1988;62:2051-5.
8. Kessler II. Cancer mortality among diabetics. J Natl Cancer Inst 1970; 44:673-86.
9. Ragozzino M, Melton LJ 3d, Chu CP, Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 1982;35:13-9.
10. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991;2:307-14.
11. Socialstyrelsen. Klassifikation av sjukdomar. (International Statistical Classification of Diseases, Injuries and Causes of Death, 1955 revision adapted for indexing of hospital records, 6th ed.). Stockholm: The National Board of Health and Welfare, 1965.
12. Socialstyrelsen. Klassifikation av sjukdomar 1968. (International Statistical Classification of Diseases, Injuries and Causes of Death, 1965 revision adapted for indexing of hospital records, 3rd ed.). Stockholm: The National Board of Health and Welfare, 1973.
13. Naessen T, Parker R, Persson I, Zack M, Adami HO. Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983 [see comment citation in Medline]. Am J Epidemiol 1989;130:289-99.
14. Socialstyrelsen. Klassifikation av sjukdomar 1987. (International Classification of Diseases, Ninth Revision). Stockholm: The National Board of Health and Welfare, 1986.
15. Mattsson B, Rutqvist LE, Wallgren A. Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int J Epidemiol 1985; 14:64-9.
16. The Cancer Registry. Cancer incidence in Sweden 1965-1989 (annual publication), Stockholm: The National Board of Health and Welfare, 1969-1992.
17. Adami HO, Hsing AW, McLaughlin JK, Trichopoulos D, Hacker D, Ekbom A, et al. Alcoholism and liver cirrhosis in the etiology of primary liver cancer. Int J Cancer 1992;51:898-902.
18. Perry IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men [see comment citation in Medline]. BMJ 1995;310:560-4.
19. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men [see comment citations in Medline]. BMJ 1995;310:555-9.
20. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res 1990;50:7415-21.
21. Farber E. Cell proliferation as a major risk factor for cancer: a concept of doubtful validity. Cancer Res 1995;55:3759-62.
22. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989;59:1145-56.
23. Flyvbjerg A, Orskov H. Growth hormone, insulin-like growth factors and diabetes. In: Alberti KG, Krall LP, editors. The diabetes annual 5. Amsterdam: Elsevier Science Publishers, 1990:642-56.
24. Lorenzi M, Cagliero E. Pathobiology of endothelial and other vascular cells in diabetes mellitus. Call for data. Diabetes 1991;40:653-9.
25. Davies MJ, Rayman G, Gray IP, Day JL, Hales CN. Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 1993;10:313-20.
26. Kahn CR, White MF. Molecular mechanism of insulin action. In: DeGroot LJ, editor. Endocrinology. Philadelphia: Saunders, 1995:1373-88.
27. Russell WE, Van Wyk JJ. Peptide growth factors. In: DeGroot LJ, editor. Endocrinology. Philadelphia: Saunders, 1995:2590-623.
28. Tabor E. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 1994; 42:357-65.
29. McKeigue PM, Laws A, Chen YD, Marmot MG, Reaven GM. Relation of plasma triglyceride and apoB levels to insulin-mediated suppression of nonesterified fatty acids. Possible explanation for sex-difference in lipoprotein pattern. Arterioscler Thromb 1993;13:1187-92.
30. Ferrara A, Barrentt-Connor E, Wingard DL, Edelstein SL. Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status. The Rancho Bemardo Study, 1984-1987. Diabetes Care 1995;18:220-5.
31. Nagore N, Scheuer PJ. The pathology of diabetic hepatitis [see comment citation in Medline]. J Pathol 1988;156:155-60.
32. Silverman JF, O'Brien KJ, Long S, Leggett N, Khazanie PG, Pories WJ, et al. Liver pathology in morbidly obese patients with and without diabetes [see comment citation in Medline]. Am J Gastroenterol 1990;85:1349-55.
33. Kaklamani E, Trichopoulos D, Tzonou A, Zavitsanos X, Koumantaki Y, Hatzakis A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991;265:1974-6.
34. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994;21:1135-9.
35. Petrides AS. Liver disease and diabetes mellitus. Diabetes Rev 1994;2:2-18.
36. Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in non-alcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988;95:1056-62.
37. Berkson J. Limitations of the application of four-fold tables to hospital data. Biometrics Bull 1946;2:47-53.
38. Stone BG, Gavaler JS, Belle SH, Shreiner DP, Peleman RR, Sarva RP, et al. Impairment of gallbladder emptying in diabetes mellitus. Gastroenterology 1988;95:170-6.
39. Lowenfels AB, Lindstrom CG, Conway MJ, Hastings PR. Gallstones and risk of gallbladder cancer. J Natl Cancer Inst 1985;75:77-80.
40. Ekbom A, Hsieh CC, Yuen J, Trichopoulos D, McLaughlin JK, Lan SJ, et al. Risk of extrahepatic bileduct cancer after cholecystectomy. Lancet 1993;342:1262-5.
41. Chow WH, Gridley G, Nyren O, Linet MS, Ekbom A, Fraumeni JF Jr, et al. Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst 1995;87:930-1.
42. Manne J, Argeson AC, Siracusa LD. Mechanisms for the pleiotropic effects of the agouti gene [see comment citations in Medline]. Proc Natl Acad Sci U S A 1995;92:4721-4.